Add to ORKGThe antiphospholipid syndrome was initially described in 1986. To reassess the validity of antiphospholipid antibodies in systemic lupus erythematosus (SLE), 95 patients with SLE were studied. Their antiphospholipid antibody profile was analysed and correlated with clinical findings such as thrombosis, abortions, or thrombocytopenia. A low prevalence of these antibodies was found (13 patients; 14%) with a high specificity for thrombosis (92%) and abortions (92%). The importance of anticardiolipin antibodies as a risk factor for thrombosis or abortions, or both, in patients with SLE is reaffirmed by this work
Objective. Different prevalences of antiphospholipid antibodies (aPL) have been reported in differen...
Backgroud. Which factors determine venous thrombotic events in some antiphospholipid syndrome (APS) ...
The antiphospholipid syndrome is defined as the association between the presence of antiphospholipid...
The antiphospholipid syndrome was initially described in 1986. To reassess the validity of antiphosp...
Antiphospholipid antibodies (aPL) have been linked to various clinical manifestations in systemic lu...
Anti-cardiolipin antibodies have been recently described in patients with systemic lupus erythematos...
The objective is to investigate the role of clinically significant antiphospholipid antibodies (aPL)...
The antiphospholipid syndrome (APS) is an autoimmune disease characterized by the occurrence of veno...
The main objectives of the present study were to determine the prevalence of IgG and IgM anticardiol...
Antiphospholipid syndrome is an autoimmune disorder defined as association of vascular thrombosis an...
OBJECTIVE: Lupus anticoagulant and anticardiolipin antibodies (aCL) have been associated with thromb...
The Antiphospholipid antibody Syndrome (APS) is characterised by recurrent thromboembolic phenomena,...
Antiphospholipid antibodies (aPL): lupus anticoagulant (LA), anticardiolipin antibodies (aCL) and an...
Lupus anticoagulant (LA), anticardiolipin (aCL), and/or antiphospholipid (aPL) antibodies are the ha...
Background: Anti-phospholipid syndrome (APS) and systemic lupus erythematous (SLE) are autoimmune di...
Objective. Different prevalences of antiphospholipid antibodies (aPL) have been reported in differen...
Backgroud. Which factors determine venous thrombotic events in some antiphospholipid syndrome (APS) ...
The antiphospholipid syndrome is defined as the association between the presence of antiphospholipid...
The antiphospholipid syndrome was initially described in 1986. To reassess the validity of antiphosp...
Antiphospholipid antibodies (aPL) have been linked to various clinical manifestations in systemic lu...
Anti-cardiolipin antibodies have been recently described in patients with systemic lupus erythematos...
The objective is to investigate the role of clinically significant antiphospholipid antibodies (aPL)...
The antiphospholipid syndrome (APS) is an autoimmune disease characterized by the occurrence of veno...
The main objectives of the present study were to determine the prevalence of IgG and IgM anticardiol...
Antiphospholipid syndrome is an autoimmune disorder defined as association of vascular thrombosis an...
OBJECTIVE: Lupus anticoagulant and anticardiolipin antibodies (aCL) have been associated with thromb...
The Antiphospholipid antibody Syndrome (APS) is characterised by recurrent thromboembolic phenomena,...
Antiphospholipid antibodies (aPL): lupus anticoagulant (LA), anticardiolipin antibodies (aCL) and an...
Lupus anticoagulant (LA), anticardiolipin (aCL), and/or antiphospholipid (aPL) antibodies are the ha...
Background: Anti-phospholipid syndrome (APS) and systemic lupus erythematous (SLE) are autoimmune di...
Objective. Different prevalences of antiphospholipid antibodies (aPL) have been reported in differen...
Backgroud. Which factors determine venous thrombotic events in some antiphospholipid syndrome (APS) ...
The antiphospholipid syndrome is defined as the association between the presence of antiphospholipid...